Their hypothesis that doxycycline, a non-toxic antibiotic drug could, act either as an MMP-2 inhibitor or as an anti-neoplastic chemotherapeutic agent in osteosarcoma cells proved realistic. The gene discussed is MMP2; the disease is osteosarcoma.